Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Lindholm, LH (author)

Ibsen, H (author)

Borch-Johnsen, K (author)

show more...

Olsen, MH (author)

Wachtell, K (author)

Dahlof, B (author)

Devereux, RB (author)

Beevers, G (author)

de Faire, U (author)

Karolinska Institutet

Fyhrquist, F (author)

Julius, S (author)

Kjeldsen, SE (author)

Kristianson, K (author)

Karolinska Institutet

Lederballe-Pedersen, O (author)

Nieminen, MS (author)

Omvik, P (author)

Oparil, S (author)

Wedel, H (author)

Aurup, P (author)

Edelman, JM (author)

Snapinn, S (author)

show less...

 (creator_code:org_t)

Ovid Technologies (Wolters Kluwer Health), 2002

2002

English.

In: Journal of hypertension. - : Ovid Technologies (Wolters Kluwer Health). - 0263-6352. ; 20:9, s. 1879-1886

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)